Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Mayer

Showing results (1-10 of 146) with videos related to

Pageof 15
Sort By:
Vnitrni Lekarstvi|January 7, 2005
[Quality of therapeutic control of hyperlipidemias in secondary prevention of coronary heart disease in the light of current recommendations]O Mayer, O Mayer
Casopis Lekaru Ceskych|May 12, 2001
[On the article by Dr. R. Ceska, et al: Fenofibrat Pharmavit SR 250 in patients with mixed hyperlipoproteinemia]O Mayer
Zdravotnicka Pracovnice|July 1, 1975
[Observations on conducting sex education in secondary schools]O Mayer
Monatsschrift Fur Ohrenheilkunde Und Laryngo-Rhinologie|March 19, 2010
About the emergence of new bone formation in the scala tympani of the basal turn in otosclerosisO MAYER
Vnitrni Lekarstvi|July 18, 2008
[Alcohol and cardiovascular risk--editorial]O Mayer
Vnitrni Lekarstvi|March 1, 1995
[Pharmacokinetics and pharmacodynamics of calcium channel blockers]O Mayer
Casopis Lekaru Ceskych|July 3, 1998
[Calcium channel blockers in the treatment of hypertension and ischemic coronary disease. Conflicts in their evaluation]O Mayer
Proceedings of the Royal Society of Medicine|December 9, 2009
The Pathology of OtosclerosisO Mayer
Wiener Beitrage Zur Hals-, Nasen- Und Ohrenheilkunde|February 19, 2014
[Petrositis]O MAYER
Activitas Nervosa Superior|January 1, 1974
Proceedings: The effect of sodium gamma-hydroxybutyrate on the CNS of rats and miceO Mayer
Pageof 15

Showing results (1-10 of 146) with videos related to

Sort By:
Pageof 15
Vnitrni Lekarstvi|January 7, 2005
[Quality of therapeutic control of hyperlipidemias in secondary prevention of coronary heart disease in the light of current recommendations]O Mayer, O Mayer
Casopis Lekaru Ceskych|May 12, 2001
[On the article by Dr. R. Ceska, et al: Fenofibrat Pharmavit SR 250 in patients with mixed hyperlipoproteinemia]O Mayer
Zdravotnicka Pracovnice|July 1, 1975
[Observations on conducting sex education in secondary schools]O Mayer
Monatsschrift Fur Ohrenheilkunde Und Laryngo-Rhinologie|March 19, 2010
About the emergence of new bone formation in the scala tympani of the basal turn in otosclerosisO MAYER
Vnitrni Lekarstvi|July 18, 2008
[Alcohol and cardiovascular risk--editorial]O Mayer
Vnitrni Lekarstvi|March 1, 1995
[Pharmacokinetics and pharmacodynamics of calcium channel blockers]O Mayer
Casopis Lekaru Ceskych|July 3, 1998
[Calcium channel blockers in the treatment of hypertension and ischemic coronary disease. Conflicts in their evaluation]O Mayer
Proceedings of the Royal Society of Medicine|December 9, 2009
The Pathology of OtosclerosisO Mayer
Wiener Beitrage Zur Hals-, Nasen- Und Ohrenheilkunde|February 19, 2014
[Petrositis]O MAYER
Activitas Nervosa Superior|January 1, 1974
Proceedings: The effect of sodium gamma-hydroxybutyrate on the CNS of rats and miceO Mayer
Pageof 15